Plain-English translation of NCT06708429 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is trying to understand how your immune system works in Lynch syndrome — specifically, whether certain immune markers in your blood can predict who is at highest risk for developing colorectal cancer. Researchers will collect blood and tissue samples from people with Lynch syndrome, both those who have developed cancer or precancerous growths and those who have not, to compare these immune markers between groups.
People with Lynch syndrome have a very high risk of colorectal cancer even when they receive regular screening colonoscopies. By identifying early immune markers that signal cancer development, doctors may be able to identify which patients need more intensive monitoring or new preventive treatments in the future.
You likely qualify if…
You likely don't qualify if…
You will have blood and tissue samples collected during your regular colonoscopy or surgical procedure — no extra visits are needed. The researchers will analyze these samples to look for immune markers and microRNA patterns that may indicate cancer risk. You may be followed over time as part of the study to see whether these markers change or predict future cancer development.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States
Italy